Simultaneous Measurement of Progesterone and Androgen Receptors in Human Prostate: A Microassay*
- 1 December 1982
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 55 (6) , 1089-1099
- https://doi.org/10.1210/jcem-55-6-1089
Abstract
The characteristics of binding of radiolabeled progesterone, promegestone [17α,21-dimethyl-19-nor-4,9-pregnadiene- 3,20-dione (R5020)], medroxyprogesterone acetate (4- pregnen-6a-methyl-17α-ol-3,20-dione acetate), and methyltrienolone [17β-hydroxy-17α-methyl-4,9,ll-estratriene-3-one (MT)] to the progesterone receptor in human prostatic cytosol have been compared. MT binds to both androgen and progesterone receptors with high affinity (Kd = 0.9 and 0.6 nM, respectively). The binding of MT to the progesterone receptor can be blocked by adding an excess of unlabeled triamcinolone acetonide [9afluoro- llβ,16α,17α,21-tetrahydroxy-l,4-pregnadiene-3,20-dione- 16,17-acetonide (TAC)]. The difference between the binding of [3H] MT in the absence and presence of TAC (i.e. [MT - (MT + TAC)]) represents specific binding of MT to the progesterone receptor. Ligand specificity studies demonstrated that this binding was typical of a progesterone receptor. Furthermore, progesterone receptor levels measured in this way were comparable to those obtained using progesterone, R5020, or medroxyprogesterone acetate as labeled ligands. Progesterone receptor quantitation from the difference MT - (MT + TAC) is of particular advantage when simultaneous quantitation of progesterone and androgen receptors is desired in small tissue specimens, since only three sets of incubations are required: [3H] MT, [3H] MT plus unlabeled TAC, and [3H] MT plus unlabeled MT (to measure nonspecific binding). Conditions are described for the application of this methodology to a microassay. A marked underestimate of progesterone receptor content was observed when incubation was terminated with hydroxylapatite compared to that measured when dextran-coated charcoal was used. The presence of comparable amounts of progesterone and androgen receptors in human prostatic cytosol deserves further investigation. (J Clin Endocrinol Metab55: 1089, 1982)Keywords
This publication has 26 references indexed in Scilit:
- Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffersAnalytical Biochemistry, 1978
- HYDROXYLAPATITE MICROMETHOD FOR MEASURING ESTROGEN-RECEPTOR IN HUMAN BREAST-CANCER1978
- DEMONSTRATION OF A PROGESTIN RECEPTOR IN HUMAN BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC CARCINOMA1978
- Characterization of the Binding of a Potent Synthetic Androgen, Methyltrienolone, to Human TissuesJournal of Clinical Investigation, 1978
- Cytosol progesterone receptors of the rat uterus: Assay and receptor characteristicsThe Journal of Steroid Biochemistry and Molecular Biology, 1977
- BINDING OF METHYLTRIENOLONE (R1881) TO A PROGESTERONE RECEPTOR-LIKE COMPONENT OF HUMAN PROSTATIC CYTOSOLJournal of Endocrinology, 1977
- ANDROGEN AND INITIATION OF PROTEIN-SYNTHESIS IN PROSTATE - BINDING OF MET-TRNAFMET TO CYTOSOL INITIATION-FACTOR AND RIBOSOMAL-SUBUNIT PARTICLES1977
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- Comparative Binding Specificity of Methyltrienolone in Human and Rat ProstateHormone Research, 1976
- A graphic method for the determination and presentation of binding parameters in a complex systemAnalytical Biochemistry, 1967